LONDON, ONTARIO--(Marketwire - May 12, 2008) - Stellar Pharmaceuticals Inc. (“Stellar” or the “Company”) (TSX VENTURE: SLX) (OTCBB: SLXCF) announced that as of the date of this release the Company has purchased 80,000 shares under its normal course issuer bid.
